ArticleScientific reports2024
Significance of the proton energy loss mechanism to gold nanoparticles in proton therapy: a Geant4 simulation.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Resolving the contradiction between simulation and experimental results of using gold nanoparticles in proton therapy.Scientific reports · 2026Article
- Radiosensitization effects of BaTiO₃ and gold nanoparticles in proton therapy of pancreatic tumors: A Monte Carlo study.Iranian journal of basic medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The biological effectiveness in proton therapy is only slightly greater than of the treatment by X-ray and hence, many researches have suggested the use of gold nanoparticles for increasing the ionization interactions to produce more secondary electrons and elevate the yield of DNA damage. But the ionization interactions also lead to protons energy loss inside the nanoparticles. The present study shows that, the protons slowed-down by High-Z nanoparticles are responsible for dose enhancement rather than the produced secondary electrons. To this purpose, using Geant4 Monte Carlo tool, one million nanoparticles distributed in a proton irradiated volume and variation of the proton's spectra and the dose related to this variation has been demonstrated. It was found that, the elevation in proton's LET values when passing through the gold nanoparticles will lead to a more significant dose enhancement than the increased dose due to the extra secondary electrons. Also, it was found that, the mechanism of protons slowing-down by gold nanoparticles has another useful aspect in proton therapy in which, the dose leakage to surrounding healthy tissues will be reduced which must be considered in future investigations more precisely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.